376 related articles for article (PubMed ID: 31932268)
21. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised.
Nam YH; Park MR; Nam HJ; Lee SK; Kim KH; Roh MS; Um SJ; Son CH
Allergol Immunopathol (Madr); 2015; 43(1):19-24. PubMed ID: 24388810
[TBL] [Abstract][Full Text] [Related]
22. DRESS syndrome: a detailed insight.
Behera SK; Das S; Xavier AS; Selvarajan S
Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
[TBL] [Abstract][Full Text] [Related]
23. Clinical features, treatment outcomes and prognostic factors of allopurinol-induced DRESS in 52 patients.
Liu Q; Zhao S; Chen W
J Clin Pharm Ther; 2022 Sep; 47(9):1368-1378. PubMed ID: 35971667
[TBL] [Abstract][Full Text] [Related]
24. Case Series on DRESS: An Unpredictable Adverse Drug Reaction.
Fatima M; Azimi SS; Ashwini S; Radhakrishna MH
Mediterr J Rheumatol; 2023 Jun; 34(2):245-251. PubMed ID: 37654627
[TBL] [Abstract][Full Text] [Related]
25. Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.
Rubin L; Talmon A; Ribak Y; Kessler A; Martin Y; Haran TK; Shamriz O; Adini I; Tal Y
Front Immunol; 2023; 14():1134178. PubMed ID: 37187735
[TBL] [Abstract][Full Text] [Related]
26. A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.
Mehrholz D; Urban AE; Herstowska M; Nowicki R; Cubała W; Barańska-Rybak W
Psychiatr Pol; 2017 Dec; 51(6):1079-1093. PubMed ID: 29432504
[TBL] [Abstract][Full Text] [Related]
27. Antituberculosis drug-induced non-blistering systemic severe reactions: A 10-year (2012-2022) literature review.
Rizzi A; Nucera E; Urbani S; Longhino D; Lohmeyer FM; Gambassi G; Krishnamra N; Gammeri L; Gangemi S; Inchingolo R
Asian Pac J Allergy Immunol; 2023 Dec; 41(4):273-291. PubMed ID: 37874314
[TBL] [Abstract][Full Text] [Related]
28. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
[TBL] [Abstract][Full Text] [Related]
29. [DRESS syndrome].
Adamcová M; Šturdík I; Koller T; Payer J
Vnitr Lek; 2016 Apr; 62(4):334-7. PubMed ID: 27250614
[TBL] [Abstract][Full Text] [Related]
30. DRESS Syndrome or Hematologic Malignancy?: A Case Report of a 4-Year-Old Boy.
Besli GE; Yildirim S; Yilmaz K; Yuksel E
Pediatr Emerg Care; 2017 Jul; 33(7):494-496. PubMed ID: 28665895
[TBL] [Abstract][Full Text] [Related]
31. DRESS syndrome in a patient with cystic fibrosis: A case report.
Gohy S; Froidure A; Lebecque P
Pediatr Pulmonol; 2017 Apr; 52(4):E18-E21. PubMed ID: 27740720
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of DRESS Syndrome in the Elderly: A Comparative Study of 55 Patients.
Bahloul E; Trimeche K; Sellami K; Hammami F; Hayder F; Chaabouni R; Amouri M; Masmoudi A; Mseddi M; Boudeya S; Turki H
Dermatitis; 2024; 35(1):55-60. PubMed ID: 37669109
[No Abstract] [Full Text] [Related]
33. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database.
Agier MS; Boivin N; Maruani A; Giraudeau B; Gouraud A; Haramburu F; Jean Pastor MJ; Machet L; Jonville-Bera AP
Br J Dermatol; 2016 Nov; 175(5):1067-1069. PubMed ID: 27060861
[No Abstract] [Full Text] [Related]
35. Antituberculosis Drug-Associated DRESS: A Case Series.
Allouchery M; Logerot S; Cottin J; Pralong P; Villier C; Ben Saïd B;
J Allergy Clin Immunol Pract; 2018; 6(4):1373-1380. PubMed ID: 29274824
[TBL] [Abstract][Full Text] [Related]
36. Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review.
Awad A; Goh MS; Trubiano JA
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1856-1868. PubMed ID: 36893848
[TBL] [Abstract][Full Text] [Related]
37. Dress syndrome in 7-year-old male child - case report.
Prylińska M; Dworakowska-Kicińska M; Krogulska A
J Mother Child; 2021 Jan; 24(3):45-48. PubMed ID: 33470957
[TBL] [Abstract][Full Text] [Related]
38. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS).
Santiago F; Gonçalo M; Vieira R; Coelho S; Figueiredo A
Contact Dermatitis; 2010 Jan; 62(1):47-53. PubMed ID: 20136879
[TBL] [Abstract][Full Text] [Related]
39. Drug reaction with eosinophilia and systemic symptoms in pediatric patients: A clinicopathological study of 16 cases in the National Center of Pharmacovigilance of Tunisia.
Kaabi W; Zaiem A; Aouinti I; Charfi O; Kastalli S; El Aidli S; Daghfous R; Lakhoua G
Therapie; 2019 Oct; 74(5):531-535. PubMed ID: 31023620
[TBL] [Abstract][Full Text] [Related]
40. An Uncommon Presentation of DRESS Syndrome Secondary to Leflunomide Use: A Case Report.
Rao S; Sunkara A; Srivastava N; Sampat P; Ramos C; Albert E
J Investig Med High Impact Case Rep; 2021; 9():2324709621997282. PubMed ID: 33629602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
